Myeloid Therapeutics to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
CAMBRIDGE, Mass., April 15, 2024 /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage biotechnology company advancing RNA immunotherapies to conquer cancer, today announced its participation at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit, taking place virtually April 29-30.
Daniel Getts, Ph.D., Chief Executive Officer of Myeloid, will participate in a fireside chat on Monday, April 29, 2024, at 11:30 am ET. Company management will also participate in one-on-one meetings with investors during the event.
About Myeloid Therapeutics
Myeloid Therapeutics is a clinical stage immunology company, engineering cutting-edge RNA technology to program immune cells to combat cancer and other deadly diseases. Myeloid is headquartered in Cambridge, MA.
The Charleston Digital Corridor is proud to welcome Fexillon, an innovative leader in digitising the built environment, to its esteemed community as the company establishes its US office in Charleston, South Carolina. This strategic collaboration...
Trees capture and store carbon from the atmosphere, improve air and water quality, make our urban spaces shadier, cooler and more enjoyable, and can provide new habitat for wildlife. To bring these benefits to Canadians, and to support good jobs for...
Amgen will host a webcasted call for the investment community at 1:00 p.m. PT on Monday, May 20, 2024 following the presentation of new data from TEZSPIRE® in chronic obstructive pulmonary disease (COPD) at the American Thoracic Society (ATS)...
The Lion Electric Company ("Lion" or the "Company"), a leading manufacturer of all-electric medium and heavy-duty urban vehicles, today held its annual meeting of shareholders (the "Meeting") as a virtual meeting. A total of 124,783,928 common...
Four astronauts will participate in a welcome home ceremony at Space Center Houston after recently returning from a mission aboard the International Space Station....
